Clariane SE's Other Operating Expense for the
six
months ended in Dec. 2025 was €2,311 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was €4,607 Mil.
Clariane SE's quarterly Other Operating Expense
increased
from Dec. 2024 (€2,294 Mil) to Jun. 2025 (€2,296 Mil) and
increased
from Jun. 2025 (€2,296 Mil) to Dec. 2025 (€2,311 Mil).
Clariane SE's annual Other Operating Expense
increased
from Dec. 2023 (€4,275 Mil) to Dec. 2024 (€4,555 Mil) and
increased
from Dec. 2024 (€4,555 Mil) to Dec. 2025 (€4,607 Mil).
Clariane SE Other Operating Expense Related Terms
Clariane SE Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Clariane SE's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €4,607 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of €4,607 Mil mean?
Clariane SE (CHIX:CLARIP) has a Other Operating Expense of €4,607 Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on Clariane SE and its competitors.
Is Clariane SE's Other Operating Expense too high?
Clariane SE's current Other Operating Expense is €4,607 Mil. Overall, Clariane SE has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's Other Operating Expense compare to HCA and THC?
Clariane SE's Other Operating Expense of €4,607 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Healthcare Providers & Services company?
A good Other Operating Expense depends on the Healthcare Providers & Services industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Clariane SE and its competitors. Clariane SE's current Other Operating Expense is €4,607 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (CHIX:CLARIP) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.47, compared to a current price of €4.13 — trading 67% above its estimated fair value. The current Other Operating Expense is €4,607 Mil. Clariane SE's overall GF Score™ is 63/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Clariane SE (CHIX:CLARIP), the current Other Operating Expense is €4,607 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clariane SE (CHIX:CLARIP) Overvalued in 2026?
Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued.
The current stock price of €4.13 is trading 67% above its estimated GF Value™ of €2.47.
GuruFocus considers Clariane SE to be Significantly Overvalued.
Key valuation signals for CHIX:CLARIP:
Other Operating Expense: €4,607 Mil
GF Value™: €2.47 vs. price of €4.13 (67% above fair value)
No single metric tells the full story. See the CHIX:CLARIP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
63GF Score
Get the complete analysis for CHIX:CLARIP
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:CLARIP has been successfully added to your 
